title: Sphingolipid metabolism and atherosclerosis.
abstract: Atherosclerosis is the major cause of mortality in the developed countries. Although presently known risk factors have some predictive value for the disease, a major part of the variability in this process remains unexplained. It is extremely important to find new approaches for better understanding of the disease and for treating it. Exploration of the sphingolipid metabolism is one of these approaches. Sphingolipids are a large class of lipids with structural and signaling functions. Recent researches indicated that these lipids play important roles in the development of atherosclerosis. In this chapter, we summarized the major findings in the field.
authors.affiliation: Department of Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA. XJiang@downstate.edu
authors.forename: Xian-Cheng
authors.initials: XC
authors.lastname: Jiang
authors.forename: Jing
authors.initials: J
authors.lastname: Liu
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy / Q000378:metabolism*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D015195:Drug Design; D006801:Humans; D008246:Lysophospholipids / Q000378:metabolism; D058990:Molecular Targeted Therapy; D015398:Signal Transduction / Q000187:drug effects; D013107:Sphingolipids / Q000378:metabolism*; D013109:Sphingomyelins / Q000378:metabolism; D013110:Sphingosine / Q000031:analogs & derivatives / Q000378:metabolism
chemical_list: D002317:Cardiovascular Agents; D008246:Lysophospholipids; D013107:Sphingolipids; D013109:Sphingomyelins; C060506:sphingosine 1-phosphate; D013110:Sphingosine